Qube Research & Technologies LTD Orgenesis Inc. Call Options Transaction History
Qube Research & Technologies LTD
- $62.3 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ORGS
# of Institutions
20Shares Held
1.61MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA910KShares$491,5350.0% of portfolio
-
Geode Capital Management, LLC Boston, MA283KShares$152,8610.0% of portfolio
-
Black Rock Inc. New York, NY79.9KShares$43,1400.0% of portfolio
-
State Street Corp Boston, MA78.9KShares$42,5940.0% of portfolio
-
Ronit Capital LLP54.2KShares$29,2500.1% of portfolio
About Orgenesis Inc.
- Ticker ORGS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,545,800
- Market Cap $13.8M
- Description
- Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed POCare therapeutics that are processed and produced in closed automated POCare technology systems across a collaborative POCare network. It focuses on autologous therapies, ...